Profile data is unavailable for this security.
About the company
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development and manufacturing organization (CDMO) services to global pharmaceutical companies, biotechnology companies, scientific research institutions, and others, including small molecule chemical drugs, peptide drugs, conjugated drugs and small nucleic acid drugs. The CDMO projects served by the Company involve therapeutic areas such as anti-tumor, anti-heart failure, anti-depression, treatment of Parkinson's disease, anti-lung cancer, anti-virus, anti-diabetes, and anti-respiratory system infection.
- Revenue in CNY (TTM)5.25bn
- Net income in CNY989.32m
- Incorporated1998
- Employees4.88k
- LocationZhejiang Jiuzhou Pharmaceutical Co LtdNo.99, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
- Phone+86 57 688706789
- Fax+86 57 688706788
- Websitehttp://www.jiuzhoupharma.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.18bn | 208.25m | 12.40bn | 1.55k | 59.56 | 5.51 | -- | 10.50 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.43bn | 523.43m | 13.13bn | 8.41k | 25.29 | 1.84 | -- | 2.04 | 0.202 | 0.202 | 2.49 | 2.78 | 0.5568 | 2.39 | 4.60 | 764,058.90 | 5.02 | 6.77 | 7.25 | 10.50 | 54.36 | 63.24 | 9.02 | 11.10 | 1.53 | 40.71 | 0.1459 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 13.15bn | 1.49k | -- | 5.46 | -- | 68.73 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.25bn | 989.32m | 13.91bn | 4.88k | 14.02 | 1.60 | -- | 2.65 | 1.10 | 1.10 | 5.84 | 9.69 | 0.4523 | 1.87 | 4.36 | 1,076,055.00 | 8.52 | 10.10 | 11.07 | 13.69 | 35.80 | 34.64 | 18.83 | 16.26 | 2.07 | -- | 0.1816 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 13.95bn | 2.53k | 22.57 | 4.72 | -- | 4.07 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 14.25bn | 965.00 | 40.47 | 2.86 | -- | 13.28 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
Suzhou Zelgen Biopharmaceuticals Co Ltd | 386.57m | -260.85m | 14.50bn | 867.00 | -- | 9.10 | -- | 37.50 | -1.00 | -1.00 | 1.49 | 6.02 | 0.1621 | 0.2594 | 3.75 | 445,874.00 | -11.74 | -27.13 | -20.82 | -39.20 | 92.29 | 92.75 | -72.40 | -220.71 | 2.15 | -- | 0.3842 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 15.06bn | 1.24k | 27.67 | 3.68 | -- | 7.86 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 15.29bn | 11.61k | 17.83 | 1.20 | -- | 1.30 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 15.50bn | 3.36k | 779.23 | 0.5313 | -- | 1.39 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
Holder | Shares | % Held |
---|---|---|
Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 63.81m | 7.68% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 32.46m | 3.91% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 15.54m | 1.87% |
Hwabao WP Fund Management Co., Ltd.as of 30 Sep 2023 | 13.95m | 1.68% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 13.45m | 1.62% |
Morgan Stanley Huaxin Fund Management Co., Ltd.as of 31 Dec 2023 | 11.31m | 1.36% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 9.22m | 1.11% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 8.57m | 1.03% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 6.84m | 0.82% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 6.27m | 0.76% |